Search Results 1761-1770 of 16992 for monoclonal antibody

  1. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Participants who are hepatitis C antibody positive will need to have a negative PCR result before randomization. Those who are hepatitis C PCR positive will ...

  2. A Study of Nulojix® (Belatacept) as Maintenance Immunosuppression in Kidney Transplant Recipients - Mayo Clinic

    Recipients with Epstein-Barr virus (EBV) serostatus negative or unknown · History of acute rejection within 3 months prior to enrollment · History of antibody ...

  3. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  4. Breastmilk in Response to a Bout of Exercise - Mayo Clinic

    ... antibodies, or who are on thyroid hormone replacement, and within one year otherwise; Abuse of alcohol or recreational drugs; Active tobacco smoking within ...

  5. Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications - Mayo Clinic

    Complex RBC antibody profiles; Need for the use of irradiated RBCs. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

  6. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors - Mayo Clinic

    Any cancer-directed therapy (chemotherapy, antibody therapy, radiotherapy, hormonal ... 200 IU/mL; HCV antibody test results are positive, and HCV (hepatitis C ...

  7. A Study of the Safety and Effectiveness of Atezolizumab Combined with Etoposide, and Carboplatin for Patients with Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

    Prior treatment with cluster of differentiation 137 (CD137) agonists or immune checkpoint blockade therapies, anti-PD1, and anti-PD-L1 therapeutic antibody ...

  8. Publications - Sean S. Park, M.D., Ph.D. - Mayo Clinic

    Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models. Sci Rep. 2024 Aug 22; 14 ...

  9. Diphtheria, tetanus, acellular pertussis, polio vaccine (intramuscular route) - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given only to children 4 to 6 years ...

  10. Halting the circle: Comprehensive neurogenetics test panels - Mayo Clinic

    Mayo Clinic's test is a single evaluation that incorporates both antibodies commonly associated with NAM — HMGCR-IgG and SRP-IgG. The detection of SRP-IgG ...